The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse.
Ferdinando Nicoletti(University of Catania), Gianni Garotta(Roche (Switzerland)), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Maria Gaetana Di Mauro(University of Milan), Paola Zaccone(University of Catania), Roberto Di Marco(University of Catania), Gaetano Magro(University of Catania), Sebastiano Grasso(University of Catania), L Mughini(University of Milan)
Cited by 72
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508